Envoy Medical Profit Margin

The latest profit margin for COCH is -98.76% as of March 2026. That compares with -92.09% in the prior-year period — down 7.2% year over year. That is below the sector sector average of 19.69%. Investors often review this figure alongside Envoy Medical's historical trend and sector peers before judging valuation or financial health.

Over the past year, COCH's profit margin moved from -92.09% to -98.76% — a 7.2% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Envoy Medical's valuation or profitability profile.

Against its sector companies, COCH currently prints -98.76% for profit margin, while the sector average sits near 19.69%. That is roughly 50252.1% below the sector mean. Large gaps often invite a closer look at Envoy Medical's growth, margins, and balance sheet.

Profit Margin shows how effectively Envoy Medical converts resources into returns. At -98.76%, COCH may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -92.09% in the prior-year period — down 7.2% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting COCH's profit margin (-98.76%), review year-over-year change from -92.09%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.